Salarius Pharmaceuticals
SLRX
SLRX
57 hedge funds and large institutions have $81.9M invested in Salarius Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 3 closing their positions.
Holders
57
Holders Change
+7
Holders Change %
+14%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
24
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $5K | 412 | -2,005 | -83% |
|
|
MTIP
52
Magee Thomson Investment Partners
San Diego,
California
| $5K | 375 | – | – |
|
|
AIS
53
Accurate Investment Solutions
Seven Fields,
Pennsylvania
| $5K | 400 | +400 | New |
|
|
PA
54
Perceptive Advisors
New York
| $3K | 237 | +237 | New |
|
55
Barclays
London,
United Kingdom
| $3K | 294 | +266 | +950% |
|
56
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $9 | 722 | – | – |
|
|
CS
57
Credit Suisse
Zurich,
Switzerland
| – | – | -12,979 | Closed |
|
|
A
58
Abingworth
London,
United Kingdom
| – | – | -10,000 | Closed |
|
59
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -251 | Closed |
|
60
Wells Fargo
San Francisco,
California
| $0 | 10 | -12 | -55% |
|
|
TDC
61
Thompson Davis & Co
Richmond,
Virginia
| – | – | – | – |
|